Literature DB >> 185925

Azathioprine: effects on neuromuscular transmission.

K L Dretchen, V H Morgenroth, F G Standaert, L F Walts.   

Abstract

The neuromuscular effects of azathioprine were examined in the in-vivo cat soleus muscle preparation. In concentrations ranging from 10 to 1,000 mug/kg, administered intra-arterially, the agent caused motor axons to fire repetitively and produced a dose-related increase in the force of contraction. The drug reversed neuromuscular blockage produced by d-tubocurarine and potentiated the neuromuscular blockade produced by succinylcholine. The effects of theophylline, a phosphodiesterase inhibitor, on neuromuscular transmission were identical to those produced by azathioprine. Using an in-vitro assay preparation, azathioprine was found to produce 50 per cent inhibition (IC50) of phosphodiesterase at a concentration of 2 X 10(-5) M. In the same preparation, theophylline had an IC50 of 1 X 10(-4) M. Neither agent in concentrations to 10(-2) M affected cholinesterase activity measured in vitro. It is concluded that the effects of azathioprine on neuromuscular transmission are due to inhibition of phosphodiesterase in the motor nerve terminal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185925

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

2.  Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?

Authors:  Koichi Takita; Yukiko Goda; Osamu Kemmotsu; Atsushi Okuyama; Tadayoshi Ito; Hiroshi Sakamoto; Hideyuki Mashio; Hiroshi Kawahigashi
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

3.  Oral cyclosporine-vecuronium interaction.

Authors:  P Ganjoo; P Tewari
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

4.  Resistance to pancuronium in an asthmatic patient treated with aminophylline and steroids.

Authors:  I Azar; D Kumar; A M Betcher
Journal:  Can Anaesth Soc J       Date:  1982-05

Review 5.  Clinical pharmacokinetics of the non-depolarising muscle relaxants.

Authors:  M I Ramzan; A A Somogyi; J S Walker; C A Shanks; E J Triggs
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

Review 6.  Myasthenia gravis--current concepts.

Authors:  C Herrmann; J M Lindstrom; J C Keesey; D G Mulder
Journal:  West J Med       Date:  1985-06

7.  Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine.

Authors:  A Sidi; R F Kaplan; R F Davis
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

Review 8.  Adverse reactions and interactions of the neuromuscular blocking drugs.

Authors:  D Ostergaard; J Engbaek; J Viby-Mogensen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.